SPI-directed Analgesia for Vitreoretinal Surgeries

NACompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

May 31, 2017

Conditions
Vitreoretinal SurgeriesPostoperative Nausea and VomitingPostoperative Pain
Interventions
DRUG

Metamizol

in group A patients will receive pre-emptive analgesia using intravenous infusion of metamizol in a single dose of 1-1,25 gram

DRUG

Acetaminophen

in group P patients will receive pre-emptive analgesia using intravenous infusion of acetaminophen in a single dose of 10-15 mg per kg of body weight

DRUG

0,5 % bupivacaine with of 2% lidocaine

in group PBB patients in group BF will receive regional peribulbar block using a solution of 0,5% bupivacaine (2,5 ml) with 2% lidocaine (2,5 ml)

DRUG

Proxymetacaine

in group T patients will receive topical analgesia using a solution of 0,5% Alcaine

Trial Locations (1)

41-200

Medical University of Silesia, Sosnowiec

All Listed Sponsors
collaborator

Silesian University of Medicine

OTHER

lead

Medical University of Silesia

OTHER

NCT02973581 - SPI-directed Analgesia for Vitreoretinal Surgeries | Biotech Hunter | Biotech Hunter